AIM
CELG

Acropolis Investment Management’s Celgene Corp CELG Stock Holding History

Acropolis Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,269
Closed -$114K – 159
2018
Q3 		$114K Sell
1,269
-135
-10% -$11.9K 0.02% 135
2018
Q2 		$112K Buy
+1,404
New +$117K 0.02% 136
2018
Q1 		– Sell
-1,081
Closed -$113K – 156
2017
Q4 		$113K Sell
1,081
-29
-3% -$3.27K 0.02% 144
2017
Q3 		$162K Hold
1,110
– – 0.03% 122
2017
Q2 		$144K Buy
+1,110
New +$136K 0.02% 133

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acropolis Investment Management's CELG Position: Q4 2018 in Review

Acropolis Investment Management sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 1,269 shares — an estimated $114K sold.

Acropolis Investment Management first reported a position in CELG in Q2 2017 and held it in 5 quarters. The position peaked at $162K in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Acropolis Investment Management reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Acropolis Investment Management sold 1,269 Celgene Corp shares in Q4 2018, an estimated $114K.
  • Acropolis Investment Management first reported a position in Celgene Corp in Q2 2017 and held it in 5 quarters.
  • Acropolis Investment Management's Celgene Corp position peaked at $162K in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Acropolis Investment Management's 13F filing for Q4 2018, filed 10 Jan 2019.